Houria Hendel‐Chavez

B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: A six‐month, national, multicenter, open‐label study

Jérémie Sellam, Houria Hendel‐Chavez, Stéphanie Rouanet et al. · Arthritis & Rheumatism · 2011 · 155 citations

Life Sciences, Immunology, Internal Medicine +17

Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B‐cell non‐Hodgkin lymphomas, ANRS HC‐13 lympho‐C study

Jean‐Marie Michot, Danielle Canioni, Henda Driss et al. · American Journal of Hematology · 2014 · 116 citations

Medicine, Hematology, Oncology +16

Use of Whole‐Blood Transcriptomic Profiling to Highlight Several Pathophysiologic Pathways Associated With Response to Rituximab in Patients With Rheumatoid Arthritis: Data From a Randomized, Controlled, Open‐Label Trial

Jérémie Sellam, Sandrine Marion‐Thore, Florent Dumont et al. · Arthritis & Rheumatology · 2014 · 62 citations

Life Sciences, Immunology, Molecular Biology +17

Interruption of Antiretroviral Therapy Initiated during Primary HIV-1 Infection: Impact of a Therapeutic Vaccination Strategy Combined with Interleukin (IL)-2 Compared with IL-2 Alone in the ANRS 095 Randomized Study

Cécile Goujard, Fabienne Marcellin, Houria Hendel‐Chavez et al. · AIDS Research and Human Retroviruses · 2007 · 53 citations

Life Sciences, Immunology, Infectious Diseases +16

CCL19, a B Cell Chemokine, Is Related to the Decrease of Blood Memory B Cells and Predicts the Clinical Response to Rituximab in Patients With Rheumatoid Arthritis

Jérémie Sellam, Stéphanie Rouanet, Houria Hendel‐Chavez et al. · Arthritis & Rheumatism · 2013 · 52 citations

Life Sciences, Immunology, Pharmacology +17